Altogether, these results shed light on the role of PD-L1 in cancer cells and suggest that PD-L1_1 and its high affinity variants can become powerful antitumor weapons that can be used alone or in combination with other drugs, to achieve more potent antitumor effects. The gene discussed is CD274; the disease is cancer.